Robert J. Polzer
Scientific AdvisorDr. Robert J. Polzer, also known as Rob, served as Executive Vice President and President of Research & Development at Zoetis Inc. since January 01, 2022 until December 31, 2025 and serves as its Scientific Advisor through 2026 and served as its Senior Vice President of Global Therapeutics until January 01, 2022. He joined the Zoetis Inc. in 2015. He began his career as a research scientist at Pfizer, where he specialized in research to predict drug metabolism by the human body. He served as the Head of Worldwide Pharmacokinetics, Dynamics and Metabolism at Pfizer before joining Zoetis at its global R&D headquarters in Kalamazoo, MI, in 2015. He has built a career around biotech innovations and pharmacokinetics in human and animal health and he has been pivotal in looking at how animal health can translate scientific innovations from human health – like monoclonal antibodies and immunotherapies – into breakthrough advances for treating pets and livestock. He has also played a key role in fostering external collaborations with institutions like Colorado State University, which is developing new immunotherapies that could pave the way for alternatives to antibiotics in food-producing animals and Regeneron, which is exploring the connections between animal and human health. He graduated from Muhlenberg College in 1989 with a bachelor’s degree in Chemistry and German Literature and then completed his Ph.D. in Medicinal Chemistry at Purdue University in 1993.
Positions
- Company NameZoetis Inc.Stock CodeZTSPositionScientific AdvisorColleagues
- KCKristin C. PeckCEO & Director
- MBMichael Benedict McCAllisterIndependent Non-Executive Chairman
- RLRoxanne LaganoExecutive VP, General Counsel & Corporate Secretary
- WNWetteny N. JosephSpecial Advisor to the CEO
- JBJamie BrannanExecutive VP & Chief Commercial Officer
- FAFrank A. D'AmelioIndependent Director
- GNGregory NordenIndependent Director
- GDGavin D. K. HattersleyIndependent Director
